Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huada Protein R&D Center (BPRC) is a prominent biotechnology organization specializing in proteomics and protein engineering. Established in 2001 as a joint venture involving BGI (formerly Beijing Genomics Institute), the Chinese Academy of Sciences, and the Beijing Municipal Government, the center serves as a core facility for large-scale protein identification and functional analysis. BPRC is internationally recognized for its leadership in the Human Liver Proteome Project (HLPP), the inaugural project of the International Human Proteome Organization (HUPO). The center offers comprehensive services including mass spectrometry-based proteomics, recombinant protein expression, and custom antibody development. By bridging genomics and functional proteomics, BPRC supports global efforts in biomarker discovery, drug target validation, and clinical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Huada Protein R&D Center.